Istituto Oncologico Veneto (IOV), IRCCS

Padua

1 studies enrolling now · 1 studies all time

What they study most

Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, Multiple Myeloma, Myelodysplastic Syndromes

Studies at this site

• A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) — Recruiting now